Related Experiment Video

Updated: Aug 20, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

[Meningococcal disease]

S Dittmann1

  • 1Arbeitsgemeinschaft Meningokokken des Deutschen Grünen Kreuzes e.V. sd.internat.immun.consult@t-online.de

Deutsche Medizinische Wochenschrift (1946)
|December 4, 2004
PubMed

Insights

Meningococcal diseases pose significant health risks globally. While vaccines exist for serogroups A, C, Y, and W, a serogroup B vaccine is still developing, necessitating ongoing discussions on immunization strategies.

Area of Science:

  • Bacteriology
  • Epidemiology
  • Vaccinology

Context:

  • Meningococcal diseases, caused by Neisseria meningitidis, present a substantial global health challenge with high fatality rates.
  • Serogroups A, B, and C are predominant worldwide, with serogroups B and C being most common in Europe, primarily affecting young children and adolescents.
  • Existing polysaccharide vaccines cover serogroups A, C, Y, and W-135, but a vaccine for serogroup B remains under development.

Purpose:

  • To review the epidemiology of meningococcal diseases and current vaccination strategies.
  • To discuss the impact of newly developed conjugated meningococcal vaccines, particularly for serogroup C.
  • To highlight the ongoing need for effective immunization strategies, especially concerning serogroup B and rising serogroup C cases.

Summary:

  • Conjugated meningococcal vaccines against serogroup C have proven effective, leading to successful control programs in countries like the UK and Netherlands.
  • In Germany, the Standing Committee on Vaccination (STIKO) recommends immunization for specific risk groups, but physicians can administer all licensed vaccines.
  • The increasing incidence of meningococcal C disease necessitates further discussion on immunization strategies, with a focus on protecting vulnerable populations.

Impact:

  • Successful implementation of meningococcal C conjugate vaccines has led to significant disease control in several European nations.
  • The development of new vaccines and ongoing epidemiological surveillance are crucial for managing and preventing meningococcal disease outbreaks.
  • Physicians play a vital role in advising patients on available immunization options against life-threatening meningococcal infections.

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.